Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Sahajanand Medical Technologies Shares List at Nearly 8% Premium on IPO Debut

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Sahajanand Medical Technologies Shares List at Nearly 8% Premium on IPO Debut

Analysed 23 Oct 2026·2 sources analysed·New Delhi, India·Business
Sahajanand Medical Technologies Shares List at Nearly 8% Premium on IPO DebutPreviousNext

Shares of Sahajanand Medical Technologies Ltd, a cardiac stent manufacturer, debuted on October 23 with an approximately 8% premium over the IPO price of Rs 344. The stock opened at Rs 371.15 on NSE and Rs 368.05 on BSE, with market capitalization around Rs 3,740-3,766 crore. The Rs 475-crore IPO, fully an offer for sale by existing shareholders, was subscribed 14.2 times, led by strong institutional demand. The listing outperformed grey market expectations amid broader market declines.

Sentiment
66%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (66/100). Lens Score 38/100.

Outlets measured: news18, moneycontrol. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 23 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (66/100)

Sentiment was consistent across outlets (65–68/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

moneycontrol broke this story on 23 Oct, 04:51 am. Other outlets followed.

23 Oct, 04:51 am2 sources · 5 h23 Oct, 10:00 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Adani Total Gas Raises CNG Prices by Rs 4.45 per Kg Citing Rising LNG Costs
Next →
Legal Challenges Arise as Businesses Integrate Artificial Intelligence Technologies
1
moneycontrol23 Oct, 04:51 am
Sahajanand Medical Technologies shares debut at 8 premium on NSE -- should you buy, sell or hold?- Moneycontrol.com
  • 2
    news1823 Oct, 10:00 am
    Sahajanand Medical Technologies shares listed at nearly 8 pc premium
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Sahajanand Medical Technologies LimitedSahajanand Medical Technologies

    Story context

    Category
    Business
    Location
    New Delhi, India
    Sources analysed
    2
    Last analysed
    23 Oct 2026
    Key entities
    Indian rupeeNational Stock Exchange of IndiaStock exchangeBombay Stock ExchangeMarket capitalizationCroreCommon stockInitial public offeringShareholderNew DelhiPress Trust of IndiaBSE SENSEX